Taldeki Bio

Taldeki BioSolutions is a cutting-edge biotech spin-off from CIC biomaGUNE, dedicated to revolutionizing biomolecular recognition through hybrid nanosensor technology. Our innovative platform enables the rapid and highly specific detection of antibodies related to infectious and autoimmune diseases, allergies, and therapeutic antibody treatments. With a strong intellectual property portfolio—including patents granted in the USA, Canada, Europe and Japan—our technology leverages hybrid mimetic antigens and advanced detection techniques such as fluorescence and catalysis. Our first program targets Hepatitis C Virus (HCV), with ongoing developments in diabetes, celiac disease, and other STDs. Supported by leading research institutions and venture acceleration programs, our multidisciplinary team of experts in protein engineering, biosensing, business development, and technology transfer is committed to delivering next-generation diagnostic solutions.